Home Tags Alembic Pharmaceuticals

Tag: Alembic Pharmaceuticals

Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 110 mg.
Branding and Advertising

Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 110 mg.

Passionate in Marketing -
0
Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 110 mg.
Branding and Advertising

Alembic Pharmaceuticals announces USFDA Tentative Approval for Ivosidenib Tablets 250 mg

Passionate in Marketing -
0
Alembic Pharmaceuticals announces USFDA Approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval for Dabigatran Etexilate Capsules, 110 mg
Marketing Analytics

Alembic Pharmaceuticals announces USFDA Approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval for Dabigatran Etexilate Capsules, 110 mg

Passionate in Marketing -
0
Alembic Pharmaceuticals announces USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%
Branding and Advertising

Alembic Pharmaceuticals Receives 5 USFDA Product Approvals in Q1FY25

Passionate in Marketing -
0
Alembic Pharmaceuticals announces USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%
article

Alembic Pharmaceuticals Limited Receives Establishment Inspection Report (EIR) for its Oncology Formulation Facility at Panelav

Passionate in Marketing -
0
Alembic Pharmaceuticals appoints Mr. Manish Kejriwal as Independent Director
Latest from Marketing World

Alembic Pharmaceuticals appoints Mr. Manish Kejriwal as Independent Director

Passionate in Marketing -
0
Alembic Pharmaceuticals Received 8 USFDA Approvals in Q3FY24 
article

Alembic Pharmaceuticals Received 8 USFDA Approvals in Q3FY24 

Passionate in Marketing -
0

© Passionate In Marketing